MARKET

STIM

STIM

Neuronetics
NASDAQ
4.825
+0.025
+0.52%
Opening 10:31 03/28 EDT
OPEN
4.800
PREV CLOSE
4.800
HIGH
4.840
LOW
4.800
VOLUME
4.40K
TURNOVER
0
52 WEEK HIGH
4.990
52 WEEK LOW
1.030
MARKET CAP
143.57M
P/E (TTM)
-4.5804
1D
5D
1M
3M
1Y
5Y
Neuronetics Inc Shrinks Board Following Strategy Review
TipRanks · 2h ago
Top 5 Health Care Stocks That May Plunge In March
Five stocks in the health care sector are overbought as of March 28, 2024. The RSI is a momentum indicator that compares a stock's strength on days when prices go up to its weakness. The Pennant Group, Inc. Is one of the five stocks with an RSI value of 90.
Benzinga · 10h ago
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Neuronetics, Inc. Granted inducement awards of 135,000 shares of the Company’s common stock to eleven new non-executive employees. Neuronetics is a commercial stage medical technology company. The company is focused on developing products that improve the quality of life for neurohealth disorders.
Barchart · 1d ago
Buy Rating for Neuronetics Amid FDA Clearance and Expanding Adolescent MDD Market
TipRanks · 2d ago
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Landos Biopharma, Inc. Shares jumped 171.2% to $21.70 on Monday. AbbVie and Landos signed a definitive agreement to acquire the company. Altamira Therapeutics Ltd. Shares climbed 70.1% after falling around 22% on Friday. GameStop Corp. Shares rose 8.4% after the company announced a separation.
Benzinga · 3d ago
Neuronetics Shares Climb 15% After FDA Cleared Depression Treatment for Adolescents Aged 15 to 21
Neuronetics shares are up 15% to $4.85. The company's stock has surged 69% since the beginning of the year. The FDA has cleared its treatment for the treatment of major depressive disorder in adolescent patients aged 15 to 21. About 4.3 million U.S. Adolescents are affected by the disorder.
Dow Jones · 3d ago
Neuronetics gets FDA nod for NeuroStar as add-on treatment for adolescents with depression
Neuronetics gets FDA nod for NeuroStar as add-on treatment for adolescents with depression. The medical technology firm's stock jumped 20% in premarket trading. NeuroStar is a transcranial magnetic stimulation treatment for the treatment of major depressive disorder in adolescents aged 15-21.
Seeking Alpha · 3d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Landos Biopharma (NASDAQ:LABP) shares moved upwards by 181.6% to $22.05 during Monday's pre-market session. Altamira Therapeutics shares rose 49.71% after their Q4 earnings report came out yesterday. Neuronetics stock increased by 18.19% in pre- market.
Benzinga · 3d ago
More
About STIM
Neuronetics, Inc. is a commercial-stage medical technology company. The Company is focused on designing, developing and marketing products for patients who suffer from neurohealth disorders. Its commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The NeuroStar Advanced Therapy System is used to treat adult patients with major depressive disorder (MDD). The Company intends to continue to pursue development of its NeuroStar Advanced Therapy System for additional indications. The Company sells its NeuroStar Advanced Therapy System and recurring treatment sessions in the United States. Its primary focus is on selling to psychiatrists, with primary care physicians and pain management specialists.

Webull offers Neuronetics Inc stock information, including NASDAQ: STIM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STIM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading STIM stock methods without spending real money on the virtual paper trading platform.